Regarding cerebellar function, Spatola et al. (2020) incorporated the Scale for the Assessment and Rating of Ataxia (SARA) as a measure of severity in patients with anti-mGluR1 encephalitis [67], but this scale has yet to be validated in the AE cohort. This evidence concerns the gene GRM1 and viral encephalitis.